Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 575-582

  Russo, Rossella ^a   Cavaliere, Federica ^a   Rombolà, Laura ^a   Gliozzi, Micaela ^b   Cerulli, Angelica ^a,c   Nucci, Carlo ^c   Fazzi, Elisa ^d   Bagetta, Giacinto ^a   Corasaniti, Maria Tiziana ^b,c   Morrone, Luigi Antonio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

coenzyme Q10; excitotoxicity; glaucoma; microdialysis neuroprotection; oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; DIZOCILPINE; FREE RADICAL; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; UBIDECARENONE;

ALZHEIMER DISEASE; CELL DEATH; DEGENERATIVE DISEASE; EXCITOTOXICITY; GLAUCOMA; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL; RETINA ISCHEMIA; REVIEW;

ANIMALS; CALPAIN; CELL DEATH; GLAUCOMA; GLUTAMIC ACID; HUMANS; INTRAOCULAR PRESSURE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; REPERFUSION INJURY; RETINA; RETINAL GANGLION CELLS; UBIQUINONE;

EID: 53049096965     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01139-4     Document Type: Review

References (60)

1. Abu-Amero K.K., Morales J., and Bosley T.M. Mitochondrial abnormalities in patients with primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2533-2541
2. Adachi K., Kashii S., Masai H., Ueda M., Morizane C., Kaneda K., Kume T., Akaike A., and Honda Y. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 236 (1998) 766-774
3. Barnett N.L., Pow D.V., and Bull N.D. Differential perturbation of neuronal and glial glutamate transport systems in retinal ischaemia. Neurochem. Int. 39 (2001) 291-299
4. Beal M.F. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. Biofactors 9 (1999) 261-266
5. Beal M.F. Therapeutic effects of coenzyme Q10 in diseases. Methods Enzymol. 382 (2004) 473-487
6. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58 (2005) 495-505
7. Beal M.F., and Matthews R.T. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol. Aspects Med. 18 Suppl (1997) 169-179
8. Billups B., and Attwell D. Modulation of non-vesicular glutamate release by pH. Nature 379 (1996) 171-174
9. Branca D. Calpain-related diseases. Biochem. Biophys. Res. Commun. 322 (2004) 1098-1104
10. Cleren C., Yang L., Lorenzo B., Calingasan N.Y., Schomer A., Sireci A., Wille E.J., and Beal M.F. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J. Neurochem. 104 (2008) 1613-1621
11. Dreyer E.B., and Grosskreutz C.L. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG). Clin. Neurosci. 4 (1997) 270-273
12. Duchen M.R. Mitochondria and calcium: from cell signaling to cell death. J. Physiol. 529 (2000) 57-68
13. Ferrante R.J., Andreassen O.A., Dedeoglu A., Ferrante K.L., Jenkins B.G., Hersch S.M., and Beal M.F. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci. 22 (2002) 592-599
14. Franke T.F., Hornik C.P., Segev L., Shostak G.A., and Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 22 (2003) 8983-8998
15. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119 (1992) 493-501
16. Gross R.L., Hensley S.H., Gao F., and Wu S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Surv. Ophthalmol. 43 Suppl 1 (1999) S162-S170
17. Honkanen R.A., Baruah S., Zimmerman M.B., Khanna C.L., Weaver Y.K., Narkiewicz J., Waziri R., Gehrs K.M., Weingeist T.A., Boldt H.C., Folk J.C., Russell S.R., and Kwon Y.H. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch. Ophthalmol. 121 (2003) 183-188
18. Izzotti A., Saccà S.C., Cartiglia C., and De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med. 114 (2003) 638-646
19. Jabaudon D., Scanziani M., Gähwiler B.H., and Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5610-5615
20. Joo C., Cho K., Kim H., Choi J.S., and Oh Y.J. Protective role for bcl-2 in experimentally induced cell death of bovine corneal endothelial cells. Ophthalmic Res. 31 (1999) 287-296
21. Kawasaki A., Otori Y., and Barnstable C.J. Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3444-3450
22. Kitano S., Morgan J., and Caprioli J. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells. Exp. Eye Res. 63 (1996) 105-112
23. Klocker N., Cellerino A., and Bahr M. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo. J. Neurosci. 18 (1998) 1038-1046
24. Ko M.L., Hu D.N., Ritch R., and Sharma S.C. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41 (2000) 2967-2971
25. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
26. Lam T.T., Kwong J.M., and Tso M.O. Early glial responses after acute elevated intraocular pressure in rats. Invest. Ophthalmol. Vis. Sci. 44 (2003) 638-645
27. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5 (2006) 160-170
28. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330 (1994) 613-622
29. Louzada-Júnior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., and Coutinho-Netto J. Glutamate release in experimental ischemia of the retina: an approach using microdialysis. J. Neurochem. 59 (1992) 358-363
30. Lucas D.R., and Newhouse J.P. The toxic effect of sodium l-glutamate on the inner layers of the retina. AMA Arch. Ophthalmol. 58 (1957) 193-201
31. Luo X., Lambrou G.N., Sahel J.A., and Hicks D. Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2695-2705
32. Maguire G., Simko H., Weinreb R.N., and Ayoub G. Transport-mediated release of endogenous glutamate in the vertebrate retina. Pflugers Arch. 436 (1998) 481-484
33. Manabe S., Gu Z., and Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 46 (2005) 4747-4753
34. Matthews R.T., Yang L., Browne S., Baik M., and Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8892-8897
35. Muller A., Maurin L., and Bonne C. Free radicals and glutamate uptake in the retina. Gen. Pharmacol. 30 (1998) 315-318
36. Napper G.A., Pianta M.J., and Kalloniatis M. Localization of amino acid neurotransmitters following in vitro ischemia and anoxia in the rat retina. Vis. Neurosci. 18 (2001) 413-427
37. Neal M.J., Cunningham J.R., Hutson P.H., and Hogg J. Effects of ischemia on neurotransmitter release from the isolated retina. J. Neurochem. 62 (1994) 1025-1033
38. Nucci C., Tartaglione R., Cerulli A., Mancino R., Spanò A., Cavaliere F., Rombolà L., Bagetta G., Corasaniti M.T., and Morrone L.A. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int. Rev. Neurobiol. 82 (2007) 397-406
39. Nucci C., Tartaglione R., Rombolà L., Morrone L.A., Fazzi E., and Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxicology 26 (2005) 935-941
40. Osborne N.N., Casson R.J., Wood J.P., Childlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
41. Osborne N.N., Chidlow G., Wood J., and Casson R. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy. Eur. J. Ophthalmol. 13 (2003) s19-s26
42. Osborne N.N., Ugarte M., Chao M., Childlow G., Bae J.H., Wood J.P., and Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43 Suppl 1 (1999) s102-s128
43. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Zecchi-Orlandini S., Orlandini G., Carella G., Brancato R., and Capaccioli S. Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J. Biol. Chem. 278 (2003) 28220-28228
44. Patel M., Day B.J., Crapo J.D., Fridovich I., and McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron 16 (1996) 345-355
45. Rosenbaum D.M., Rosenbaum P.S., Gupta A., Michaelson M.D., Hall D.H., and Kessler J.A. Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vis. Res. 37 (1997) 3445-3451
46. Rossi D.J., Oshima T., and Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (2000) 316-321
47. Saccà S.C., Pascotto A., Camicione P., Capris P., and Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open angle glaucoma. Arch. Ophthalmol. 123 (2005) 458-463
48. Samy C.N., Lui C.J., Kaiser P.K., Lipton S.A., and Dreyer E.B. Toxicity of chronic glutamate administration to the retina. Invest. Ophthalmol. Vis. Sci. 35 (1994) 497
49. Sandhu J.K., Pandey S., Ribecco-Lutkiewicz M., Monette R., Borowy-Borowski H., Walker P.R., and Sikorska M. Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10. J. Neurosci. Res. 72 (2003) 691-703
50. Shults C.W., Beal M.F., Song D., and Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol. 188 (2004) 491-494
51. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., and Lew M. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59 (2002) 1541-1550
52. Sisk D.R., and Kuwabara T. Histologic changes in the inner retina of albino rats following intravitral injection of monosodium l-glutamate. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 250-258
53. Sucher N.J., Lipton S.A., and Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 37 (1997) 3483-3493
54. Tamm E.R., Russell P., Johnson D.H., and Piatigorsky J. Human and monkey trabecular meshwork accumulate alpha B-crystallin in response to heat shock and oxidative stress. Invest. Ophthalmol. Vis. Sci. 37 (1996) 2402-2413
55. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 25 (2006) 490-513
56. Tezel G., and Wax M.B. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2660-2667
57. Tezel G., and Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20 (2000) 8693-8700
58. Tezel G., Yang X., and Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3177-3187
59. Trotti D., Rossi D., Gjesdal O., Levy L.M., Racagni G., Danbolt N.C., and Volterra A. Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271 (1996) 5976-5979
60. White R.D., and Neal M.J. The uptake of l-glutamate by the retina. Brain Res. 111 (1976) 79-93